These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 4402535)

  • 1. Activation of leukemia viruses by graft-versus-host and mixed lymphocyte reactions in vitro.
    Hirsch MS; Phillips SM; Solnik C; Black PH; Schwartz RS; Carpenter CB
    Proc Natl Acad Sci U S A; 1972 May; 69(5):1069-72. PubMed ID: 4402535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of murine leukemia viruses in RFM mice with host versus graft disease after perinatal inoculation of (T6 X RFM)F1 lymphohemopoietic cells.
    Cross SS; Brede G; Tucker HS; Maloney M; Montour JL; Hard RC
    Infect Immun; 1983 Aug; 41(2):570-7. PubMed ID: 6135664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukemia virus activation in chronic allogeneic disease.
    Hirsch MS; Black PH; Tracy GS; Leibowitz S; Schwartz RS
    Proc Natl Acad Sci U S A; 1970 Dec; 67(4):1914-7. PubMed ID: 4395204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous induction of endogenous murine leukemia virus-related antigen expression during short-term in vitro incubation of mouse lymphocytes.
    Lonai P; Declève A; Kaplan HS
    Proc Natl Acad Sci U S A; 1974 May; 71(5):2008-12. PubMed ID: 4365582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor induction by immunologically activated murine leukemia virus.
    Armstrong MY; Ruddle NH; Lipman MB; Richards FF
    J Exp Med; 1973 May; 137(5):1163-79. PubMed ID: 4144984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocytes and leukemia viruses: tropism and transtropism of murine leukemia virus.
    Datta SK; Melief CJ; Schwartz RS
    J Natl Cancer Inst; 1975 Aug; 55(2):425-32. PubMed ID: 169376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of leukemia viruses by graft-versus-host and mixed-lymphocyte-culture reactions: electron microscopic evidence of C-type particles.
    André-Schwartz J; Schwartz RS; Hirsch MS; Phillips SM; Black PH
    J Natl Cancer Inst; 1973 Aug; 51(2):507-18. PubMed ID: 4148783
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunologic activation of murine leukemia viruses.
    Melief CJ; Datta S; Louie S; Schwartz RS
    Cancer; 1974 Oct; 34(4 Suppl):suppl:1481-7. PubMed ID: 4153907
    [No Abstract]   [Full Text] [Related]  

  • 9. Graft versus leukemia: effect of phytohemagglutinin-stimulated and normal spleen cells on Rauscher disease.
    Lair SV; Lozzio BB
    J Natl Cancer Inst; 1974 Oct; 53(4):1165-8. PubMed ID: 4427392
    [No Abstract]   [Full Text] [Related]  

  • 10. Monoclonal antibodies to xenotropic and MCF murine leukemia viruses derived during the graft-versus-host reaction.
    Portis JL; McAtee FJ; Cloyd MW
    Virology; 1982 Apr; 118(1):181-90. PubMed ID: 6281969
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunological activation of oncogenic viruses: interrelationship of immunostimulation and immunosuppression.
    Hirsch MS
    Johns Hopkins Med J Suppl; 1974; 3():177-85. PubMed ID: 4153909
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of tumors as a result of graft-versus-host reaction.
    Cornelius EA
    Exp Hematol; 1973; 1(3):135-49. PubMed ID: 4153858
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunochemotherapy of transplantable Moloney leukemia with cyclophosphamide and allogeneic spleen lymphocytes and reversal of graft-versus-host disease with alloantiserum.
    Kende M; Keys LD; Gaston M; Goldin A
    Cancer Res; 1975 Feb; 35(2):346-51. PubMed ID: 234033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiself suppressive (veto) activity of responder cells in mixed lymphocyte cultures.
    Claësson MH; Röpke C
    Curr Top Microbiol Immunol; 1986; 126():213-23. PubMed ID: 2941241
    [No Abstract]   [Full Text] [Related]  

  • 15. Autoaggressive reactions and leukemia virus infections: interrelated events in their pathogenesis.
    Hirsch MS; Proffitt MR; Black PH; Ellis DA
    Bibl Haematol; 1975; (40):319-27. PubMed ID: 240353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Participation of phytohemagglutinin-transformed mouse lymphocytes in development of the "graft-versus-host" reaction].
    Nesterenko VG; Koval'chuk LV
    Biull Eksp Biol Med; 1976 Sep; 82(9):1096-8. PubMed ID: 11013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. II. Development of natural suppressor cell activity.
    Maier T; Holda JH; Claman HN
    J Immunol; 1985 Sep; 135(3):1644-51. PubMed ID: 3160774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alleviation of chronic GVHD in mice by oral immuneregulation toward recipient pretransplant splenocytes does not jeopardize the graft versus leukemia effect.
    Ilan Y; Margalit M; Ohana M; Gotsman I; Rabbani E; Engelhardt D; Nagler A
    Hum Immunol; 2005 Mar; 66(3):231-40. PubMed ID: 15784461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-mediated immunity to antigens associated with endogenous murine C-type leukemia viruses.
    Hirsch ME; Kelly AP; Proffitt MR; Black PH
    Science; 1975 Mar; 187(4180):959-61. PubMed ID: 167435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graft-versus-host reaction in F 1 recipients in the absence of donor (parental) cell proliferation.
    Scollay RG; Hofman F; Globerson A
    Eur J Immunol; 1974 Jul; 4(7):490-3. PubMed ID: 4153366
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.